News Medical on MSN18h
Age-related decline in cardiac conduction system regeneration increases arrhythmia risk after heart attackStudy uncovers the impact of myocardial infarction on the cardiac conduction system, revealing insights into arrhythmogenesis ...
Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting ...
Discover how wearable technology is transforming pregnancy care, from real-time monitoring to early detection of ...
BACKGROUND: Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high ...
Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...
Ablation sites (maroon circular tags) abolished ventricular tachycardia in this patient.
US-based Field Medical has secured breakthrough device designation from the US Food and Drug Administration (FDA) for the FieldForce ablation system. FieldForce is the first PFA system ...
I believe that Adagio’s VT Cryoablation System with vCLAS catheter will become the future standard of care for treatment of patients with ventricular tachycardia.” Based in California ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback